Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $79.90 | Total: $399.50 |
| 1 | 10 | $67.68 | Total: $676.80 |
| 1 | 25 | $57.34 | Total: $1,433.50 |
| 1 | 50 | $48.88 | Total: $2,444.00 |
| 1 | 100 | $42.30 | Total: $4,230.00 |
Overview
Encenicline (EVP-6124) is a selective ?7 nicotinic acetylcholine receptor (nAChRs) agonist being developed to treat cognitive impairment in schizophrenia and Alzheimer's disease.
Chemical Properties
| Molecular Formula | C16H17ClN2OS |
| Molecular Weight | 320.84 |
| CAS Numbers | 550999-75-2 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | Cl.[H][C@]12CCN(CC1)C[C@@H]2NC(=O)c1cc2cccc(Cl)c2s1 |
Storage and Handling
0C Short Term, -20C Long Term
References
Prickaerts J, van Goethem NP, Chesworth R,et al.EVP-6124, a novel and selective ?7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of ?7 nicotinic acetylcholine receptors[J].Neuropharmacology. 2012 Feb;62[2] 1099-110.